Interleukin-17A, the tumor suppressor protein WW domain-containing oxidoreductase, tissue inhibitor of metalloproteinase 3 (TIMP3), and long noncoding RNA H19 polymorphisms have all been associated with clinicopathologic characteristics in lung cancers [5,9,12,13]. This evidence concerns the gene TIMP3 and lung carcinoma.